The Antoine-Lacassagne Center, Cancer Control Center of Nice, presented the Proteus® One built by the Belgian company IBA in close collaboration with the Nice-based company, AIMA DEVELOPPEMENT, the first compact proton therapy solution installed in Europe, on its site on Avenue de la Lanterne in Nice,
With the MEDICYC Cyclotron, built by its own technical team led by engineer Pierre Mandrillon, in operation since June 17, 1991, the Antoine‐Lacassagne Center (CAL) achieved the first proton irradiation in France: proton therapy.
To date, CAL has performed over 4,500 treatments with the 65 MeV proton beam delivered by MEDICYC for patients with ocular tumors (of low thickness).
This project of a new high-energy proton accelerator will allow, from the end of 2015, the treatment of certain tumors located deeper in the body. The uniqueness of the Proteus® One is to ensure better protection of healthy tissues surrounding the area to be treated (reduce the risk of complications) and to increase the dose on the tumor site (increase effectiveness).
This equipment will enhance the already innovative technical platform of CAL (linear accelerators with intensity modulation and dynamic arc therapy, stereotactic radiotherapy by CyberKnife, brachytherapy, contact therapy), always committed to personalized patient care.
In full accordance with the Cancer Plan III, the CAL offers to other French and also European healthcare institutions this new proton therapy installation within organized partnerships, as is the case with the Léon Bérard Cancer Control Center in Lyon, allowing children from the entire greater Southeast to benefit from this major technological advancement.
